ARTICLE | Distillery Therapeutics
Cancer
July 18, 2017 9:05 PM UTC
Cell culture and mouse studies suggest inhibiting Notch signaling in combination with dual EP300/CREBBP inhibitors could help treat esophageal adenocarcinoma. In two human esophageal adenocarcinoma ce...
BCIQ Company Profiles